Sign in
Download Opera News App

PFIZER

Health News Roundup: U.S. health officials releasing some Jynneos vaccine doses for monkeypox -CDC; Pfizer/BioNTech say 3 COVID shots elicit a good response in children under 5 and more

Following is a summary of current health news briefs. U.S. health officials releasing some Jynneos vaccine doses for monkeypox -CDC U.S. health officials are in the process of releasing some Jynneos vaccine doses for use in monkeypox cases, the Centers for Disease Control and Prevention (CDC) said on Monday.

devdiscourse.com ,  1 hour ago 0
Health News Roundup: U.S. health officials releasing some Jynneos vaccine doses for monkeypox -CDC; Pfizer/BioNTech say 3 COVID shots elicit a good response in children under 5 and more

Pfizer says three-dose Covid-19 vaccination 80% effective in young children

LOS ANGELES (May 24): Pfizer and its German partner BioNTech said on Monday (May 23) that preliminary clinical data showed that their three-dose Covid-19 vaccine regimen was 80% effective for children six months to five years old at preventing illness during the Omicron wave.

theedgemarkets.com ,  2 hours ago 0
Pfizer says three-dose Covid-19 vaccination 80% effective in young children

COVID-19 vaccine for keiki expected by the summer

More than two years since the start of the pandemic, keiki under five may be able, for the first time, to get immunized against COVID-19 by the summer. Still, many parents worry about a new vaccination for vulnerable children. "In the back of my mind, I'm still concerned and I would still like maybe a little bit more time to maybe see a little bit more children take it before and see how the results are," said Linden Miller, mother of a young daughter ineligible for the vaccine.

kitv.com ,  2 hours ago 0
COVID-19 vaccine for keiki expected by the summer

Pfizer says Covid shot 80% effective in young kids

IANS- Pfizer and its German partner BioNTech have said that preliminary clinical data showed their three-dose Covid-19 vaccine regimen was 80 percent effective for children aged between 6 months to 5-years-old at preventing illness during the Omicron wave. The vaccine was found to elicit a strong immune response following a third dose, and was well tolerated by the kids with a majority of the side effects mild to moderate, Xinhua news agency quoted the companies as saying on Monday.

indicanews.com ,  3 hours ago 1
Pfizer says Covid shot 80% effective in young kids

China’s bet on homegrown mRNA vaccines holds back nation

TAIPEI China is trying to navigate its biggest coronavirus outbreak without a tool it could have adopted many months ago, the kind of vaccines that have proven to offer the best protection against the worst outcomes from COVID-19. As early as the spring of 2020 a Chinese pharmaceutical company, Fosun Pharma, reached an agreement to distribute, and eventually manufacture, the mRNA vaccine made by Pfizer and BioNTech.

hurriyetdailynews.com ,  3 hours ago 0
China’s bet on homegrown mRNA vaccines holds back nation

Brokerages Anticipate Pfizer Inc. (NYSE:PFE) Will Post Quarterly Sales of $32.94 Billion

Analysts expect that Pfizer Inc. (NYSE:PFE – Get Rating) will report $32.94 billion in sales for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Pfizer’s earnings, with the highest sales estimate coming in at $33.32 billion and the lowest estimate coming in at $32.56 billion.

modernreaders.com ,  3 hours ago 0
Brokerages Anticipate Pfizer Inc. (NYSE:PFE) Will Post Quarterly Sales of $32.94 Billion

COVID-19 Booster 101: Who can get it and who is eligible for a second booster

SPRINGFIELD, Mo. (KY3) - COVID-19 cases are on the rise in Greene County, and many are wondering when to get their booster or if they should get a second booster. Local experts in Springfield say to get the booster as soon as you are eligible, five weeks after your second dose.

ky3.com ,  3 hours ago 0
COVID-19 Booster 101: Who can get it and who is eligible for a second booster

Pfizer Says 3 Covid Shots Protect Children Under 5 | world news

Three doses of Pfizer’s Covid-19 vaccine offer strong protection for children under the age of 5, the company announced Monday, a further step towards immunizations for the youngest which may start in early summer. Pfizer plans to submit the findings to US regulators later this week.

shepherdgazette.com ,  5 hours ago 0
Pfizer Says 3 Covid Shots Protect Children Under 5 | world news

Pfizer announces new data showing effectiveness of its 3-dose vaccine

FILE - A nurse holds a vial of the Pfizer COVID-19 vaccine for children ages 5 to 11, right, and a vial of the vaccine for adults, which has a different colored label, at a vaccination station in Jackson, Miss., Tuesday, Feb. 8, 2022.

kxly.com ,  5 hours ago 14
Pfizer announces new data showing effectiveness of its 3-dose vaccine

Pfizer Says Three Is a Magic Number When It Comes to Vaccines For Kids Under 5

Three doses of Pfizer’s COVID-19 vaccine offer the strongest protection for children younger than 5, the company announced Monday, another step toward shots for the littlest kids possibly beginning in early summer. Pfizer plans to submit the findings to U.S. regulators later this week. The Food and Drug Administration (FDA) already is evaluating an application by rival Moderna to offer two-dose vaccinations to infants and toddlers, and set June 15th as a tentative date for its independent scientific advisers to publicly debate the data from one or both companies.

hillreporter.com ,  6 hours ago 3
Pfizer Says Three Is a Magic Number When It Comes to Vaccines For Kids Under 5

FDA to discuss COVID-19 vaccination for infants, toddlers

STATEN ISLAND, N.Y. — The United States Food and Drug Administration (FDA) on Monday announced its advisory committee would hold a mid-June meeting to review data on COVID-19 vaccines for infants and toddlers. The committee will review data from Pfizer and Moderna to make a recommendation on whether the FDA should authorize the shots for use.

silive.com ,  6 hours ago 1
FDA to discuss COVID-19 vaccination for infants, toddlers

Pfizer COVID shot 80 percent effective in young kids, early data show

If the FDA advisory panel looks favorably on the pediatric vaccines, the agency could authorize the shots as soon as June 16 or 17. Vaccine advisers to the Centers for Disease Control and Prevention then would consider who should get the shots, with a final recommendation coming from agency director Rochelle Walensky shortly afterward.

bostonglobe.com ,  6 hours ago 0
Pfizer COVID shot 80 percent effective in young kids, early data show

Allegheny Health Network: New Pfizer vaccine likely to require three doses if approved by FDA

TRACKING THE COVID-19 VACCINE PITTSBURGH — Parents hoping for an updated COVID-19 vaccine for children 6 months to 5 years old should expect a three-dose application, based on observations from doctors at Allegheny Health Network. Watch the report in the video player above. Dr. Joseph Aracri, chairman of pediatrics, said this is based on past results of a two-dose application.

wtae.com ,  7 hours ago 3
Allegheny Health Network: New Pfizer vaccine likely to require three doses if approved by FDA

Three-Dose Covid-19 Vaccine Produces Strong Immune Responses In Children Ages Six Months To Five Years, Pfizer And BioNTech Say

(CW44 News At 10 | CNN) –Three Child-size doses of the Pfizer/BioNtech Covid-19 vaccine have shown a strong immune response in children ages six months to five years, the companies said Monday. The vaccine makers said they will finish submitting the trial data to the US Food and Drug Administration this week.

tampa.cbslocal.com ,  11 hours ago 0
Three-Dose Covid-19 Vaccine Produces Strong Immune Responses In Children Ages Six Months To Five Years, Pfizer And BioNTech Say